Table 1

 Results of serial pulmonary function tests and respiratory muscle strength among SARS survivors (n = 110)

Parameter3 months6 months
TLC, total lung capacity; VC, vital capacity; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second; RV, residual volume; Tlco, carbon monoxide transfer factor adjusted for haemoglobin; Kco, transfer coefficient (transfer factor per alveolar volume); Pimax, Pemax, maximum static inspiratory and expiratory pressures.
Values are expressed as median (interquartile range).
*p<0.01, Kco at 3 months v 6 months. No statistically significant differences were noted between other lung function parameters at 3 and 6 months.
FVC (% of predicted)104.5 (95.0–114.0)104.5 (95.0–113.0)
FEV1 (% of predicted)108.0 (99.0–118.5)106.0 (97.8–116.0)
TLC (% of predicted)104.0 (93.3–115.8)108.0 (98.0–117.0)
VC (% of predicted)105.0 (95.0–115.5)105.5 (95.0–113.5)
RV (% of predicted)108.0 (70.5–140.8)115.0 (84.0–139.8)
Tlco (% of predicted)98.0 (88.5–107.0)95.5 (85.0–106.0)
Kco (% of predicted)106.0 (98.0–115.5)110.5 (100.0–119.0)*
Pimax (% of predicted)104.0 (88.0–127.0)101.0 (87.5–125.0)
Pemax (% of predicted)74.0 (62.0–86.0)77.0 (59.0–86.0)